0001104659-23-023388.txt : 20230217
0001104659-23-023388.hdr.sgml : 20230217
20230217182108
ACCESSION NUMBER: 0001104659-23-023388
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230215
FILED AS OF DATE: 20230217
DATE AS OF CHANGE: 20230217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BRYCE RICHARD PAUL
CENTRAL INDEX KEY: 0001553037
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40356
FILM NUMBER: 23644480
MAIL ADDRESS:
STREET 1: C/O PUMA BIOTECHNOLOGY, INC.
STREET 2: 10880 WILSHIRE BOULEVARD, SUITE 2150
CITY: LOS ANGELES
STATE: CA
ZIP: 90024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Rain Oncology Inc.
CENTRAL INDEX KEY: 0001724979
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 821130967
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8000 JARVIS AVENUE
STREET 2: SUITE 204
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: (510) 953-5559
MAIL ADDRESS:
STREET 1: 8000 JARVIS AVENUE
STREET 2: SUITE 204
CITY: NEWARK
STATE: CA
ZIP: 94560
FORMER COMPANY:
FORMER CONFORMED NAME: Rain Therapeutics Inc.
DATE OF NAME CHANGE: 20171211
4
1
tm237300-3_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2023-02-15
0
0001724979
Rain Oncology Inc.
RAIN
0001553037
BRYCE RICHARD PAUL
C/O RAIN ONCOLOGY INC.
8000 JARVIS AVENUE, SUITE 204
NEWARK
CA
94560
0
1
0
0
Chief Medical Officer
Stock Option (Right to Buy)
9.30
2023-02-15
4
A
0
110000
0.00
A
2033-02-15
Common Stock
110000
110000
D
This option represents a right to purchase a total of 110,000 shares of the Issuer's common stock, one quarter of which will vest on February 15, 2024, with the remaining three quarters vesting in equal monthly installments through February 15, 2027, subject to the Reporting Person's continued service to the Issuer.
/s/ Nelson Cabatuan, Attorney-in-fact for Richard Bryce
2023-02-17